Found 9 matching trials
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
PHASE1This phase I trial studies the side effects and best dose of ADH-1 when giv...
Location
University of Nebraska Medical Center
ADH1 and ADH2 Disease Monitoring Study (DMS)
N/AA global, multi-center, Disease Monitoring Study (DMS) in participants with...
Status
Active Not Recruiting
Location
University of California, San Francisco (UCSF) - Benioff Children's Hospital - Oakland
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
PHASE3The primary purpose of the study is to understand the effectiveness, safety...
Status
Active Not Recruiting
Location
UCSF Benioff Children's Hospital, Oakland
A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors
PHASE1N-cadherin, a protein involved in blood vessel cell binding, is increased a...
Location
University of Texas M.D. Anderson Cancer Center
A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine
PHASE1N-cadherin, a protein involved in blood vessel cell binding, is increased a...
Location
Rocky Mountain Cancer Centers
Study of ADH-1 Given Intravenously to Patients With Solid Tumors
PHASE1N-cadherin, a protein involved in blood vessel cell binding, is increased a...
Location
Istituto Nazionale per lo Studio e la Cura dei Tumori
A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent
PHASE2N-cadherin, a protein involved in blood vessel cell binding, is increased a...
Location
Florida Cancer Specialist
Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)
PHASE2The overall objective of this study is to evaluate the pharmacokinetics (PK...
A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan
PHASE1N-cadherin, a protein involved in blood vessel cell binding and on the surf...
Location
University of Colorado, Denver